Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
35.67
+2.88 (8.78%)
At close: Jun 24, 2025, 4:00 PM
35.27
-0.40 (-1.12%)
After-hours: Jun 24, 2025, 7:23 PM EDT
TNXP Employees
Tonix Pharmaceuticals Holding had 81 employees as of December 31, 2024. The number of employees decreased by 22 or -21.36% compared to the previous year.
Employees
81
Change (1Y)
-22
Growth (1Y)
-21.36%
Revenue / Employee
$123,963
Profits / Employee
-$1,628,716
Market Cap
264.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
TNXP News
- 8 days ago - Tonix Pharmaceuticals: Big Risk, Bigger Reward - Initiating With A Buy - Seeking Alpha
- 8 days ago - Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025 - GlobeNewsWire
- 11 days ago - Tonix Pharmaceuticals: Is The Recent Sell-Off A Buy Occasion? - Seeking Alpha
- 11 days ago - Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors - GlobeNewsWire
- 14 days ago - Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention - GlobeNewsWire
- 19 days ago - Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025 - GlobeNewsWire
- 4 weeks ago - Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase - GlobeNewsWire
- 4 weeks ago - Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction - GlobeNewsWire